Core Technology


By leveraging professional databases and employing deep learning methodologies, we construct AI models for in-depth analysis, evaluation and screening of novel drug candidates. This enables us to rapidly identify and optimize potential candidates, substantially reduce the costs of experiments and expedite the drug discovery process.

Core Technology


By leveraging professional databases and employing deep learning methodologies, we construct AI models for in-depth analysis, evaluation and screening of novel drug candidates. This enables us to rapidly identify and optimize potential candidates, substantially reduce the costs of experiments and expedite the drug discovery process.

Core Technology


By leveraging professional databases and employing deep learning methodologies, we construct AI models for in-depth analysis, evaluation and screening of novel drug candidates. This enables us to rapidly identify and optimize potential candidates, substantially reduce the costs of experiments and expedite the drug discovery process.

R&D Pipeline

Based on AI technology and driven by unmet clinical needs, we aim to drug the undruggable targets, overcome drug resistance and minimize side effects. Our business model encompasses independent research and development, project collaborations, and licensing transactions.

About


We are committed to collaboration to drive progress, share knowledge and foster innovation. Together, we aim to amplify the impact of AI-driven drug discovery.

News


The challenges posed by intricate diseases demand a collective effort. We actively seek and participate in partnerships to explore synergies in scientific community.

Join Us


Talent is the foundation of the company. We are eager to recruit talents with backgrounds and experience in artificial intelligence, computational and medicinal chemistry, biological science, etc. to join us and embark on the innovation journey.

E-mail:
contact@lexbiotx.com
Address:
328 Xinghu Road, Suzhou Industrial Park, China